Please assess the completion status of the following clinical trial:

Trial Title: Treatment With Cannabis Oil Containing CBD, THC, CBDV or CBG vs. Placebo of Persons With ADHD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Participants aged at least 18 y/o diagnosed with ADHD by Diagnostic and Statistical Manual of Mental Disorders (DSM)~* Participants with a lower than 0 TOVA score or with a higher than 0 score whom as per investigator opinion suffer from ADHD~* Participants who experienced treatment failure with more than one ADHD conventional drug~* Participants willing to attend all the visits in the trial.~Exclusion Criteria:~* Participants who were treated with benzodiazepines, antihistamines, etc, in the week that preceded the trial start.~* Participants suffering from neurologic or psychiatric diseases~* Participants suffering from malignant diseases~* Participants suffering from syndromes or metabolic diseases~* Participants with significant clinical diagnosis that can damage the trial unfolding. The investigator may include them after the end of the situation which prevented their previous inclusion.~* Participants breastfeeding, pregnant or not willing to use contraceptives.~* Participants that will not adhere to the protocol as per investigator opinion~* Participants who weight less than 45 kg or more than 120kg or with BMI greater than 30~* Participants participating in another clinical trial which includes drug treatment~* Participants receiving any treatment for ADHD~* Participants using drugs~* Participants using cannabis or products containing cannabinoids, including medical cannabis.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CBD rich (Type: EXPERIMENTAL): Cannabis oil oral drops containing 95 mg/ml CBD; 5 mg/ml THC; 15 mg/ml CBDV ; no CBG, once daily Titration from 0.3 to 1.8 ml/day during 21 days
- CBG rich (Type: EXPERIMENTAL): Cannabis oil oral drops containing no CBD; 5 mg/ml THC; no CBDV; 95 mg/ml CBG, once daily.~Titration from 0.3 to 1.8 ml/day during 21 days
- CBD & CBG rich (Type: EXPERIMENTAL): Cannabis oil oral drops containing 47.5 mg/ml CBD; 2.5 mg/ml THC; 7.5 mg/ml CBDV; 47.5 mg/ml CBG, once daily.~Titration from 0.3 to 1.8 ml/day during 21 days
- placebo (Type: PLACEBO_COMPARATOR): Placebo oil oral drops once daily. Titration from 0.3 to 1.8 ml/day during 21 days

Based on this trial design, predict the completion outcome and termination type (if applicable).